Cardinal Health 2013 Annual Report Download - page 17

Download and view the complete annual report

Please find page 17 of the 2013 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 56

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56

Cardinal Health, Inc. and Subsidiaries
Selected Financial Data
15
The consolidated financial data below includes all business combinations as of the date of acquisition that occurred during these periods. The following
selected consolidated financial data should be read in conjunction with the consolidated financial statements and related notes and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations.”
(in millions, except per common share amounts) 2013 (1) 2012 2011 2010 2009
Earnings Data:
Revenue $ 101,093 $ 107,552 $ 102,644 $98,503 $ 95,992
Earnings from continuing operations $ 335 $ 1,070 $ 966 $587 $758
Earnings/(loss) from discontinued operations (2) (1)(1)(7)55 394
Net earnings $ 334 $ 1,069 $ 959 $642 $1,152
Basic earnings/(loss) per common share:
Continuing operations $0.98 $3.10 $2.77 $1.64 $ 2.12
Discontinued operations (2) —— (0.02)0.15 1.10
Net basic earnings per common share $ 0.98 $3.10 $2.75 $1.79 $ 3.22
Diluted earnings/(loss) per common share:
Continuing operations $0.97 $3.06 $2.74 $1.62 $ 2.10
Discontinued operations (2) —— (0.02)0.15 1.08
Net diluted earnings per common share $ 0.97 $3.06 $2.72 $1.77 $ 3.18
Cash dividends declared per common share $1.0900 $0.8825 $0.8000 $0.7200 $ 0.5950
Balance Sheet Data:
Total assets $25,819 $24,260 $22,846 $19,990 $ 25,119
Long-term obligations, less current portion 3,686 2,418 2,175 1,896 3,272
Shareholders’ equity (3) 5,975 6,244 5,849 5,276 8,725
(1) During the fourth quarter of fiscal 2013, we recognized a non-cash goodwill impairment charge of $829 million ($799 million, net of tax) related to our Nuclear Pharmacy Services
division.
(2) On August 31, 2009, we separated the clinical and medical products businesses from our other businesses (the "CareFusion Spin-Off") through a pro rata distribution to shareholders
of 81 percent of the then outstanding common stock of CareFusion Corporation ("CareFusion") and met the criteria for classification of these businesses as discontinued operations.
During the fourth quarter of fiscal 2009, we committed to plans to sell our United Kingdom-based Martindale injectable manufacturing business within our Pharmaceutical segment,
and met the criteria for classification of this business as discontinued operations.
(3) As noted above, on August 31, 2009, we completed the distribution to our shareholders of 81 percent of the then outstanding common stock of CareFusion. The distribution of CareFusion
common stock to our shareholders resulted in the recognition of a $3.7 billion non-cash dividend.